
Rexwin Pharma Private Limited
About Rexwin Pharma Private Limited
Data last updated:
Rexwin Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 16 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC294930. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohit Sharma and Abhaypratap Bhupendra Singh.
Its last annual general meeting (AGM) was held on 20 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at E – 001 Paras Apartment Vasant Nagari Play Ground Sector – 02 Vasai East, Thane, Maharashtra, India – 401208.
As per the financials filed for FY 2019, the company reported a revenue of ₹8.5 Lakh, a growth of 67% compared to the previous year. For the same year it recorded a net loss of ₹97,997 (net margin -11.5%) and EBITDA of -₹97,667 (EBITDA margin -11.5%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rexwin Pharma Private Limited's registered office is in Thane, Maharashtra.
- Registered AddressE – 001 Paras Apartment Vasant Nagari Play Ground Sector – 02 Vasai East, Thane, Maharashtra, India – 401208
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rexwin Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rexwin Pharma Private Limited, buy the company report.
Financials of Rexwin Pharma Private Limited
FY 2019 filings availableRexwin Pharma Private Limited reported revenue of ₹8.5 Lakh (up 67% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue rose 67% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹97,667 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹97,997 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -11.5% | |
| Net Profit Margin | -11.5% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Rexwin Pharma Private Limited, buy the company report.
Board of directors of Rexwin Pharma Private Limited
Rexwin Pharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohit Sharma | Director | 16 May 2017 | 9 Years 6 Months | Current |
| Abhaypratap Bhupendra Singh | Director | 16 May 2017 | 9 Years 6 Months | Current |
| Abrar Jalal Ahmed | Director | 16 May 2017 | 9 Years 6 Months | Current |
| Rikin Ram Gaikar | Director | 16 May 2017 | 9 Years 6 Months | Current |
Peer comparison
Rexwin Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sanvits Care India Private Limited | ₹8.51 Lakh (FY 2024) | 13.0% | Lucknow, Uttar Pradesh, India | |||
| Zrox Pharmaceuticals Private Limited | ₹8.51 Lakh (FY 2021) | -6.0% | Yamuna Nagar, Haryana, India | |||
| Taklan India Private Limited | ₹8.51 Lakh (FY 2020) | New Delhi, Delhi, India | ||||
| LNS Management Consulting Private Limited | ₹8.5 Lakh (FY 2020) | -46.0% | Durgapur, West Bengal, India | |||
| Lakshita Enterprises Private Limited | ₹8.5 Lakh (FY 2019) | -94.0% | Jodhpur, Rajasthan, India | |||
| Rexwin Pharma Private Limitedthis company | ₹8.5 Lakh (FY 2019) | -₹97,997 | -11.5% | 67.0% | Thane, Maharashtra, India | |
| Naini Metals Recycling Private Limited | ₹8.5 Lakh (FY 2023) | Kashipur, Uttarakhand, India | ||||
| Salasar Boutique Private Limited | ₹8.5 Lakh (FY 2025) | -87.0% | Kolkata, West Bengal, India | |||
| Satyak Trading Private Limited | ₹8.5 Lakh (FY 2018) | 41.0% | Kolkata, West Bengal, India | |||
| Vaarahai Seeds India Private Limited | ₹8.5 Lakh (FY 2024) | Hyderabad, Telangana, India | ||||
| Risestar India Distillers & Bottlers Private Limited | ₹8.5 Lakh (FY 2024) | Kashipur, Uttarakhand, India |
To see the full peer comparison of Rexwin Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rexwin Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rexwin Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rexwin Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Rexwin Pharma Private Limited, buy the company report.
Recent activity
Rexwin Pharma Private Limited has 10 board changes on record since 2017: 7 appointments and 3 cessations. The latest: Choyintavida Ashraf Vengadan ceased to be Director on 16 Dec 2019.
1 earlier event is in the company report.
Frequently asked questions
Rexwin Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 16 May 2017 (9+ years old) and is registered under CIN U74999MH2017PTC294930.
Rexwin Pharma has 4 current directors:
- Mohit Sharma - Director
- Abhaypratap Bhupendra Singh - Director
- Abrar Jalal Ahmed - Director
- Rikin Ram Gaikar - Director
The latest financial statements of Rexwin Pharma on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 20 September 2019. Year-wise statements from FY 2018 are in the company report.
No. Rexwin Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Rexwin Pharma is U74999MH2017PTC294930. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rexwin Pharma was incorporated on 16 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Rexwin Pharma by revenue are Sanvits Care India Private Limited, Zrox Pharmaceuticals Private Limited, Taklan India Private Limited, LNS Management Consulting Private Limited, Lakshita Enterprises Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Choyintavida Ashraf Vengadan ceased to be Director on 16 Dec 2019. Jaspreet Singh ceased to be Director on 16 Dec 2019. Choyintavida Ashraf Vengadan was appointed as Director on 01 Nov 2019. Rexwin Pharma has 10 board changes on record in total.
The registered office of Rexwin Pharma is at E – 001 Paras Apartment Vasant Nagari Play Ground Sector – 02 Vasai East, Thane, Maharashtra, India – 401208.
Rexwin Pharma operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Rexwin Pharma is compliant as of 06 September 2026. The company is actively filing with the Registrar of Companies.

